These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 18314601)

  • 1. [On the role of transcription factor family AP-2 for development and disease--lessons from mouse models].
    Schorle H
    Verh Dtsch Ges Pathol; 2007; 91():91-7. PubMed ID: 18314601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma.
    Ødegaard E; Staff AC; Kaern J; Flørenes VA; Kopolovic J; Tropé CG; Abeler VM; Reich R; Davidson B
    Gynecol Oncol; 2006 Mar; 100(3):462-8. PubMed ID: 16216317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of transcription factor AP-2gamma/TFAP2C impairs branching morphogenesis of the murine mammary gland.
    Jäger R; Schäfer S; Hau-Liersch M; Schorle H
    Dev Dyn; 2010 Mar; 239(3):1027-33. PubMed ID: 20131354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual role of AP-2gamma in ErbB-2-induced mammary tumorigenesis.
    Jäger R; Friedrichs N; Heim I; Büttner R; Schorle H
    Breast Cancer Res Treat; 2005 Apr; 90(3):273-80. PubMed ID: 15830141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice.
    Vasiljeva O; Korovin M; Gajda M; Brodoefel H; Bojic L; Krüger A; Schurigt U; Sevenich L; Turk B; Peters C; Reinheckel T
    Oncogene; 2008 Jul; 27(30):4191-9. PubMed ID: 18345026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factor AP-2gamma stimulates proliferation and apoptosis and impairs differentiation in a transgenic model.
    Jäger R; Werling U; Rimpf S; Jacob A; Schorle H
    Mol Cancer Res; 2003 Oct; 1(12):921-9. PubMed ID: 14573793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
    Jacquemart IC; Springs AE; Chen WY
    Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ErbB2 overexpression in p53-inactivated mammary epithelial cells.
    Yang JW; Lee EY; Kang KW
    FEBS Lett; 2006 Nov; 580(27):6501-8. PubMed ID: 17101136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different gene-expression profiles for the poorly differentiated carcinoma and the highly differentiated papillary adenocarcinoma in mammary glands support distinct metabolic pathways.
    Eilon T; Barash I
    BMC Cancer; 2008 Sep; 8():270. PubMed ID: 18811984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cartilage-specific transcription factor Sox9 regulates AP-2epsilon expression in chondrocytes.
    Wenke AK; Grässel S; Moser M; Bosserhoff AK
    FEBS J; 2009 May; 276(9):2494-504. PubMed ID: 19476490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perianal mass in a female transgenic mouse.
    Naff KA; Van Pelt C; Craig S; Gray K
    Lab Anim (NY); 2005 Apr; 34(4):31, 32-3. PubMed ID: 15806087
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor.
    Jones RA; Campbell CI; Petrik JJ; Moorehead RA
    Mol Cancer Res; 2008 May; 6(5):819-28. PubMed ID: 18505926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AP-2γ Is Required for Maintenance of Multipotent Mammary Stem Cells.
    Gu VW; Cho E; Thompson DT; Cassady VC; Borcherding N; Koch KE; Wu VT; Lorenzen AW; van der Heide DM; White JR; Kulak MV; Williams T; Zhang W; Weigel RJ
    Stem Cell Reports; 2021 Jan; 16(1):106-119. PubMed ID: 33382976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The APC tumor suppressor is required for epithelial integrity in the mouse mammary gland.
    Prosperi JR; Becher KR; Willson TA; Collins MH; Witte DP; Goss KH
    J Cell Physiol; 2009 Aug; 220(2):319-31. PubMed ID: 19326388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAp63alpha induces AP-2gamma as an early event in epidermal morphogenesis.
    Koster MI; Kim S; Huang J; Williams T; Roop DR
    Dev Biol; 2006 Jan; 289(1):253-61. PubMed ID: 16324689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of integrin signaling in genetically engineered mouse models of mammary tumor progression.
    Pylayeva Y; Guo W; Giancotti FG
    Methods Enzymol; 2007; 426():439-61. PubMed ID: 17697895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription.
    Firlej V; Ladam F; Brysbaert G; Dumont P; Fuks F; de Launoit Y; Benecke A; Chotteau-Lelievre A
    J Cell Sci; 2008 Oct; 121(Pt 20):3393-402. PubMed ID: 18827017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted knockout of BRG1 potentiates lung cancer development.
    Glaros S; Cirrincione GM; Palanca A; Metzger D; Reisman D
    Cancer Res; 2008 May; 68(10):3689-96. PubMed ID: 18483251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
    Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A
    Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
    Vaillant F; Asselin-Labat ML; Shackleton M; Forrest NC; Lindeman GJ; Visvader JE
    Cancer Res; 2008 Oct; 68(19):7711-7. PubMed ID: 18829523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.